Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik
Ludwigshafen, Germany
Augenklinik, Ludwigshafen am Rhein, Rheinland-Pfalz
About Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik
During the past decade, Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
2006-02-17
2019-02-11
Terminated
355
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik"
#1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik
According to Clinical.Site data, the most researched conditions in "Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik" are
"Geographic Atrophy" (2 trials), "Macular Edema" (2 trials), "Branch Retinal Vein Occlusion" (1 trials), "Central Retinal Vein Occlusion" (1 trials) and "Hemiretinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik
Most popular intervention types in "Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik" are "Drug" (5 trials), "Procedure" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Aflibercept" (2 trials), "Faricimab" (2 trials), "Lampalizumab" (2 trials), "Sham Procedure" (2 trials) and "Port Delivery System with Ranibizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik
The vast majority of trials in "Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik" are
5 trials for "All" genders.
Clinical Trials Status at Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik
Currently, there are NaN active trials in "Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".